← Markets

Celanese Corporation

CE · NYSE

Market closed$45.70$-0.080000 (-0.17%)After hours $46.61 · +1.99%

Key statistics

Previous close$45.78
Open$45.80
Day high$46.57
Day low$45.22
52-week high$70.70
52-week low$35.13
Market cap5.01B
Volume1.53M
Average volume1.86M
P/E ratio10.63
Forward P/E3.66
EPS4.30
Dividend yield+0.26%

Market context

Why it moved

Celanese (CE) edged slightly lower in line with broader market weakness, as the Dow Jones Industrial Average declined on the day amid ongoing macroeconomic uncertainties, including U.S.-Iran tensions contributing to rising oil prices that pressure chemical manufacturers' input costs.

TradingeconomicsStockinvestYanmarSortiraparisFacebook

What is happening

Recent company-specific developments and publisher coverage.

July 17, 2026Celanese closed essentially flat on Thursday but is gaining roughly 2% in after-hours trading, with investor attention centered on a confluence of recent developments. Morgan Stanley cut its price target on the stock from $72 to $58 (Hold), while the broader analyst consensus remains Buy with an average target near $67 — implying significant upside from current levels. Celanese also declared a $0.03 quarterly dividend and announced the closure of its Ulsan, South Korea engineered materials facility, shifting production to China and India amid ongoing cost restructuring.

-0.1747

July 17, 2026Celanese fell sharply as Morgan Stanley cut its price target to $58 from $72, citing a commodity chemicals sector that is "out of favor" and weaker-than-expected Q2 dynamics. The analyst noted that product spreads reverted to the mean faster than projected, acetyls pricing in China moderated sooner than anticipated, and automotive exposure weighed on Engineered Materials — prompting downward EPS revisions for 2026-2028. The selloff came amid broader pressure on cyclical materials names, with Dow Inc. also declining and the basic materials sector underperforming on the day.

-3.029

July 16, 2026Celanese closed modestly lower, underperforming as the broader materials sector faced headwinds, with the XLB ETF also slipping on the session. Key investor focus remains on an unusual uptick in options activity flagged earlier in the day, suggesting the market may be pricing in a volatility event ahead — likely tied to the company's upcoming Q2 earnings report, given Q2 EPS guidance of $2.00–$2.40. Also in focus: a credit downgrade earlier in the week pressured sentiment, while Celanese's declaration of its $0.03 quarterly dividend (payable Aug. 10) offered little uplift amid ongoing concerns over the company's high debt load and margin recovery trajectory.

-1.1309

July 15, 2026Celanese closed essentially flat despite a broader market rally fueled by a cooler-than-expected June CPI report, as a credit downgrade weighed on the specialty chemicals maker. The materials sector ETF (XLB) also closed lower, suggesting sector-specific headwinds, while Celanese extended losses in after-hours trading. Analysts maintain a consensus 'Moderate Buy' with an average price target of ~$66, framing the stock as potentially 32% undervalued — but elevated debt (debt-to-equity of 2.41) and ongoing industry overcapacity remain key concerns alongside Q1 earnings that narrowly missed estimates.

-0.3548

July 14, 2026Celanese rose about 2% on Monday, outperforming a broadly weaker market pressured by U.S.-Iran tensions and a chip-sector selloff, though the stock faces a complex backdrop: a credit downgrade earlier in the session initially weighed on shares, and after-hours trading pulled back roughly 1.5%. Analysts maintain a 'Moderate Buy' consensus with an average price target of ~$66, implying significant upside from current levels, while a recent valuation analysis pegs fair value near $68.70 — framing the stock's steep 3-month decline as a potential mispricing opportunity ahead of Q2 earnings, given Q2 guidance of $2.00–$2.40 EPS.

2.1313

July 11, 2026Celanese edged higher, closing up modestly as investors look ahead to the company's Q2 2026 earnings report due July 16, with consensus revenue estimates at $2.75 billion. The stock continues to trade well below its 52-week high of $70.70, weighed by a mixed Q1 print—EPS of $0.85 missed estimates while revenue met expectations—and analyst caution, including recent target cuts from BMO Capital Markets and Mizuho. HSBC boosted its Celanese stake by over 200% in Q4, and the broader specialty chemicals sector faces input cost inflation tied to Middle East supply disruptions.

0.6003

July 10, 2026Celanese closed modestly lower as investors navigated a risk-off backdrop driven by escalating U.S.-Iran tensions, with oil prices surging on fears of Strait of Hormuz disruptions and renewed inflation concerns weighing on the broader Basic Materials sector. The decline came ahead of the company's Q2 2026 earnings report scheduled for July 16, with analyst sentiment mixed — Mizuho recently cut its price target to $55 with a neutral rating, while JPMorgan and Wells Fargo maintain overweight ratings and the consensus target sits around $66.

-1.3953

July 9, 2026Celanese shares declined amid a broad risk-off session triggered by President Trump declaring the U.S.-Iran ceasefire 'over,' sending oil prices surging over 5% and stoking inflation fears that pressured chemical and materials stocks. Adding to company-specific headwinds, BMO Capital recently cut its price target on Celanese to $57 (from $80) while maintaining a Hold rating, and Mizuho trimmed its target to $55 with a Neutral rating, reflecting persistent concerns around the company's earnings trajectory after Q1 results narrowly missed estimates and revenue fell 2.2% year-over-year. In after-hours trading, shares are recovering modestly, up about 1.75%.

-2.8348

ad-hoc-news.de · July 18, 2026Celanese stock edges higher as investors weigh pricing power and earnings momentumTradingView · July 16, 2026Celanese Corporation Stock 12‑Month Price Target Cut to $67.29, Implies 43% UpsideStock Titan · June 25, 2026Celanese sets Aug. 5 call for second-quarter 2026 resultsStock Titan · June 4, 2026South Korea loses Celanese materials plant to China, India
Mt Newswire · July 16, 2026Celanese Sees Mixed Investor Sentiment With Commodity Chemicals Sector 'Out of Favor,' Morgan Stanley Says
Benzinga · July 16, 2026Morgan Stanley Maintains Equal-Weight on Celanese, Lowers Price Target to $58
Mt Newswire · July 16, 2026Morgan Stanley Adjusts Celanese PT to $58 From $72, Maintains Equalweight Rating
Mt Newswire · July 15, 2026Celanese Keeps Quarterly Dividend at $0.03 a Share, Payable Aug. 10 to Holders of Record July 28
Benzinga · July 6, 2026BMO Capital Maintains Market Perform on Celanese, Lowers Price Target to $57
Mt Newswire · July 1, 2026Mizuho Adjusts Price Target on Celanese to $55 From $65, Maintains Neutral Rating
Benzinga · July 1, 2026Mizuho Maintains Neutral on Celanese, Lowers Price Target to $55
Mt Newswire · July 1, 2026RBC Cuts Price Target on Celanese to $48 From $68, Keeps Sector Perform Rating

Peers

S&P 500SPX · $7,457.69-1.01%Dow Inc.DJI · $29.92+2.12%Eastman Chemical CompanyEMN · $68.60-0.81%LyondellBasell Industries N.V.LYB · $59.19+2.40%DuPont de Nemours, Inc.DD · $135.29+0.74%Huntsman CorporationHUN · $11.79-0.59%The Chemours CompanyCC · $17.52+1.10%BASF SeBAS.DE · €48.55+0.27%Solvay S.A.SOLB.BR · €26.14-0.15%Lanxess AGLNXSY · $3.530.00%Asahi Kasei Corporation3407.T · ¥1,829.50-2.48%Braskem S.A.BAK · $2.46+2.50%